141 related articles for article (PubMed ID: 34293716)
1. The lncRNA OGFRP1/miR-149-5p/IL-6 axis regulates prostate cancer chemoresistance.
Wang C; Ding T; Yang D; Zhang P; Hu X; Qin W; Zheng J
Pathol Res Pract; 2021 Aug; 224():153535. PubMed ID: 34293716
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
3. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
[TBL] [Abstract][Full Text] [Related]
4. LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis.
Dong H; Liu Q; Chen C; Lu T; Xu K
Immunobiology; 2022 Mar; 227(2):152176. PubMed ID: 35066433
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
6. Ropivacaine Retards the Viability, Migration, and Invasion of Choriocarcinoma Cells by Regulating the Long Noncoding RNA OGFRP1/MicroRNA-4731-5p/HIF3A Axis.
Lu Y; Yang C; Zhang L; Ding J
Mol Biotechnol; 2022 May; 64(5):499-509. PubMed ID: 34855100
[TBL] [Abstract][Full Text] [Related]
7. LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis.
Qin H; Li X; Zhang W; Ding Z
J Mol Histol; 2022 Apr; 53(2):257-271. PubMed ID: 35050465
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
12. lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p.
Yan K; Hou L; Liu T; Jiao W; Ma Q; Fang Z; Zhang S; Song D; Liu J; Gao X; Fan Y
Aging (Albany NY); 2020 May; 12(10):8880-8892. PubMed ID: 32428870
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
14. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR-497-5p to upregulate expression of CCND1.
Zhou J; Song G; Su M; Zhang H; Yang T; Song Z
Environ Toxicol; 2023 Jun; 38(6):1251-1264. PubMed ID: 36947456
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
Xu W; Chang J; Du X; Hou J
Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA OGFRP1 regulates cell proliferation and ferroptosis by miR-299-3p/SLC38A1 axis in lung cancer.
Liu L; Su S; Ye D; Yu Z; Lu W; Li X
Anticancer Drugs; 2022 Oct; 33(9):826-839. PubMed ID: 36066402
[TBL] [Abstract][Full Text] [Related]
20. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
